{
  "format": "healthspanledger-research-release-ledger",
  "schemaVersion": 1,
  "dataset": {
    "id": "tesamorelin-adverse-effects",
    "name": "EGRIFTA 2 mg (1 mg/vial trial-formulation) table adverse-reaction incidence",
    "canonicalUrl": "https://healthspanledger.com/compounds/tesamorelin/side-effects"
  },
  "releases": [
    {
      "edition": "2026.09",
      "version": "086c38187d39",
      "retrieved": "2026-09-06",
      "sourceUpdated": null,
      "rowCount": 20,
      "note": "First recorded public release of the complete EGRIFTA 2 mg trial-formulation adverse-reaction incidence table, preserving both named arms and denominators."
    },
    {
      "edition": "2026.09",
      "version": "2796588441d8",
      "retrieved": "2026-09-06",
      "sourceUpdated": null,
      "rowCount": 20,
      "note": "Repointed the unchanged EGRIFTA incidence rows to DailyMed's official SPL XML endpoint after the human-facing label URL retired."
    }
  ]
}